120 related articles for article (PubMed ID: 18307501)
21. Amikacin pharmacokinetics in plasma and pleural fluid.
Limthongkul S; Charoenlap P; Nuchprayoon CJ; Udompanich V; Songkhla YN
J Med Assoc Thai; 1989 Feb; 72(2):90-6. PubMed ID: 2500495
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of population pharmacokinetics with NONMEM in clinical patients treated with amikacin by intravenous infusion].
Chu XM; Rui JZ; Zhou YG; Dai YJ; Cai WM; Ling SS
Yao Xue Xue Bao; 1996; 31(12):881-5. PubMed ID: 9863218
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of clindamycin HCl administered intravenously, intramuscularly and subcutaneously to dogs.
Lavy E; Ziv G; Shem-Tov M; Glickman A; Dey A
J Vet Pharmacol Ther; 1999 Aug; 22(4):261-5. PubMed ID: 10499238
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of amikacin after intravenous, intra-articular, and combined intravenous and intra-articular administration in healthy neonatal foals.
Paegelow JL; Schoonover MJ; Young JM; Maxwell LK; Taylor JD; Gilliam LL; Holbrook TC
J Vet Intern Med; 2024; 38(3):1825-1834. PubMed ID: 38647141
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of coumarin and 7-hydroxycoumarin upon i.v. and p.o. administration in the euthyroid and hypothyroid beagle dog.
Ritschel WA; Grummich KW
Arzneimittelforschung; 1981; 31(4):643-9. PubMed ID: 7195711
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of ceftriaxone administered by the intravenous, intramuscular or subcutaneous routes to dogs.
Rebuelto M; Albarellos G; Ambros L; Kreil V; Montoya L; Bonafine R; Otero P; Hallu R
J Vet Pharmacol Ther; 2002 Feb; 25(1):73-6. PubMed ID: 11874531
[TBL] [Abstract][Full Text] [Related]
27. Effects of isolation housing and timing of drug administration on amikacin kinetics in mice.
Zhou RH; Tsutsumi K; Nakano S
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):303-5. PubMed ID: 10072909
[TBL] [Abstract][Full Text] [Related]
28. Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.
Ling GV; Conzelman GM; Franti CE; Ruby AL
Am J Vet Res; 1981 Oct; 42(10):1792-4. PubMed ID: 7325444
[TBL] [Abstract][Full Text] [Related]
29. Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs.
Goldstein I; Wallet F; Robert J; Becquemin MH; Marquette CH; Rouby JJ
Am J Respir Crit Care Med; 2002 Jan; 165(2):171-5. PubMed ID: 11790649
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic longitudinal studies of antibiotics administered via a permanent intraosseous device in micropigs.
Chastagner P; Lozniewski A; Lascombes P; Barberi-Heyob M; Merthes PM; Merlin JL
Med Pediatr Oncol; 2001 Jun; 36(6):635-40. PubMed ID: 11344495
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and intramuscular bioavailability of amikacin in chickens following single and multiple dosing.
el-Gammal AA; Ravis WR; Krista LM; Tolbert DS; Saad A
J Vet Pharmacol Ther; 1992 Jun; 15(2):133-42. PubMed ID: 1433475
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of oleandomycin in dogs after intravenous or oral administration alone and after pretreatment with metamizole or dexamethasone.
Milanova A; Lashev L
Vet Res Commun; 2002 Jan; 26(1):61-71. PubMed ID: 11860088
[TBL] [Abstract][Full Text] [Related]
33. Correlations between aminoglycoside pharmacokinetic parameters and patient's factors: from statement to implication for individual dosage design.
Firsov AA; Nasonov VN
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():327-31. PubMed ID: 1820904
[TBL] [Abstract][Full Text] [Related]
34. Determination of the lifespan of erythrocytes from greyhounds, using an in vitro biotinylation technique.
Novinger MS; Sullivan PS; McDonald TP
Am J Vet Res; 1996 May; 57(5):739-42. PubMed ID: 8723892
[TBL] [Abstract][Full Text] [Related]
35. Effect of unilateral nephrectomy on the pharmacokinetics of amikacin in humans.
Drozdzik M; Domanski L; Wojcicki J; Gawronska-Szklarz B; Machoy P; Pudlo A
J Pharm Pharmacol; 2002 Apr; 54(4):509-14. PubMed ID: 11999128
[TBL] [Abstract][Full Text] [Related]
36. [Influence of total parenteral nutrition on amikacin pharmacokinetics].
Cai WM; Yu GH; Chen G
Zhongguo Yao Li Xue Bao; 1989 Sep; 10(5):428-31. PubMed ID: 2515746
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of a high dose of amikacin administered at extended intervals to neonatal foals.
Magdesian KG; Wilson WD; Mihalyi J
Am J Vet Res; 2004 Apr; 65(4):473-9. PubMed ID: 15077690
[TBL] [Abstract][Full Text] [Related]
38. Tissue and serum concentrations of amikacin after intramuscular and intrauterine administration to mares in estrus.
Orsini JA; Park MI; Spencer PA
Can Vet J; 1996 Mar; 37(3):157-60. PubMed ID: 8681283
[TBL] [Abstract][Full Text] [Related]
39. Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock.
Taccone FS; Laterre PF; Spapen H; Dugernier T; Delattre I; Layeux B; De Backer D; Wittebole X; Wallemacq P; Vincent JL; Jacobs F
Crit Care; 2010; 14(2):R53. PubMed ID: 20370907
[TBL] [Abstract][Full Text] [Related]
40. Relative pharmacokinetics of three amikacin brands in onco-hemotologic pediatric patients experiencing febrile neutropeina.
Jamshaid M; Yousuf S; Bukhari NI; Rizvi AA
Eur J Drug Metab Pharmacokinet; 2003; 28(1):1-6. PubMed ID: 14503658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
